Report overview
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
This report aims to provide a comprehensive presentation of the global market for Therapeutic Nuclear Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Nuclear Drug. This report contains market size and forecasts of Therapeutic Nuclear Drug in global, including the following market information:
Global Therapeutic Nuclear Drug Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Therapeutic Nuclear Drug market was valued at US$ 1719.4 million in 2022 and is projected to reach US$ 2152.8 million by 2029, at a CAGR of 3.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Therapeutic Nuclear Medicines key players include Bayer, Novartis AG, China Isotope & Radiation, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 47%, followed by Europe and Asia-Pac?
We surveyed the Therapeutic Nuclear Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Therapeutic Nuclear Drug Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Therapeutic Nuclear Drug Market Segment Percentages, by Type, 2022 (%)
Radium-223
Lutetium-177
Iodine-131
Other
Global Therapeutic Nuclear Drug Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Therapeutic Nuclear Drug Market Segment Percentages, by Application, 2022 (%)
Thyroid
Bone Metastasis
Lymphoma
Other
Global Therapeutic Nuclear Drug Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Therapeutic Nuclear Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Therapeutic Nuclear Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Therapeutic Nuclear Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes
Outline of Major Chapters:
Chapter 1: Introduces the definition of Therapeutic Nuclear Drug, market overview.
Chapter 2: Global Therapeutic Nuclear Drug market size in revenue.
Chapter 3: Detailed analysis of Therapeutic Nuclear Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Therapeutic Nuclear Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
